Rosette inhibition test in chronic liver disease

Area of Science:

• Immunology
• Hepatology

Background:

• Cell-mediated immunity is increasingly recognized in chronic liver diseases, alongside humoral immunity alterations.
• Understanding T-lymphocyte involvement is crucial for diagnosing and managing chronic liver conditions.

Purpose of the Study:

• To evaluate T-lymphocyte sensitization in patients with chronic liver disorders using the rosette inhibition test.
• To assess the correlation between T-lymphocyte sensitization and hepatitis B antigen status.
• To observe the effect of immunosuppressive treatment on T-lymphocyte sensitization.

Main Methods:

• Rosette inhibition test was employed to assess T-lymphocyte sensitization.
• Patients with chronic active hepatitis, primary biliary cirrhosis, and chronic persistent hepatitis were included.
• Hepatitis B antigen status was analyzed in correlation with T-lymphocyte sensitization.

Main Results:

• Cell-mediated immune reactions were detected in 81% of chronic active hepatitis patients and 71% of primary biliary cirrhosis patients.
• No T-lymphocyte sensitization was observed in patients with chronic persistent hepatitis.
• T-lymphocyte sensitization was more frequent in hepatitis B antigen-positive patients.
• Four out of nine patients receiving immunosuppressive treatment showed improvement in the test.

Conclusions:

• The rosette inhibition test is a valuable tool for detecting T-lymphocyte sensitization in specific chronic liver diseases.
• T-lymphocyte sensitization is associated with more severe forms of chronic liver disease, including hepatitis B.
• Immunosuppressive therapy may influence T-lymphocyte sensitization in these conditions.